Skip to content

Mindfulness Intervention for People With Psychosis

Mindfulness-based Interventions for People With Recent-onset Psychosis: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03501862
Enrollment
108
Registered
2018-04-18
Start date
2017-01-15
Completion date
2021-07-31
Last updated
2021-09-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recent-onset Psychosis

Keywords

Mindfulness, Cognitive therapy

Brief summary

People with psychosis demonstrated a tendency to use maladaptive cognitive emotion regulation strategies as compared with healthy control groups. The present study is the first randomized controlled trial of group mindfulness-based intervention for psychosis. Half group will join the mindfulness-based cognitive intervention while another half will participate in psychoeducation to examine whether mindfulness will have a positive impact on emotion regulation and distress.

Detailed description

Concurrently with positive and negative symptoms, affective symptoms and full affective disorder episodes are common in psychotic disorders particularly in the acute phase of illness. Affective symptoms are a significant risk factor accounting for approximately 5-6% of suicide rates which remain or becomes higher shortly after a psychotic episode or hospital discharge (American Psychiatric Association, 2013). It has been proved that the emotion management and cognitive reappraisal were negatively associated with schizophrenia. In the study, it is hypothesized that the intervention will have a positive impact on psychotic symptoms, general symptoms such as affective symptoms, psychological flexibility, mindfulness skills, quality of life and re-hospitalization by facilitating strategies on emotion regulation.

Interventions

BEHAVIORALMindfulness-based cognitive therapy (psychosis)

A small group intervention is based on a structured and validated protocol that will include mindfulness practice, cognitive skills

BEHAVIORALPsychoeducation (psychosis)

A small group intervention will be focusing on understanding of psychosis, treatment, relapse prevention and useful information and resources.

Sponsors

Edinburgh Napier University
CollaboratorOTHER
The Hong Kong Polytechnic University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Assignment to the study groups will be made independently of staff involved in the recruitment and management of participants in the study.

Intervention model description

Participants referred to the study will be assessed at a screening examination to ensure eligibility and obtain written consent by a research assistant. Eligible participants will undertake a further interview on outcome measures prior to randomization within 3 weeks the commencement of intervention. Eligible participants will be randomly assigned to receive Mindfulness-based Cognitive Therapy for Psychosis (MBCTp) plus TAU or TAU plus Psychoeducation for Psychosis (PEp). Simple randomization will be used to ensure that participants will have equal opportunity to be included into the study (Altaman and Bland, 1999).

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Must be Chinese residents and aged above 18 * Have a primary diagnosis of psychosis (non-affective) and/or other psychotic disorders met the Diagnostic and Statistical Manual DSM-5 * Have been diagnosed equivalent to or less than 5 years * Mentally stable as assessed by the researcher and a psychiatrist to comprehend the education and training provided (a pre-recruitment briefing session for potential participants will be conducted to verify their ability to follow instructions and understanding in participation, and case files will be reviewed to ensure a stable medication regime for at least 6 months) in order to ensure their ability to make a valid consent * Able to read and understand Chinese

Exclusion criteria

* Have recently participated in (less than 3 months) or are receiving other structured psycho-education and/or psychotherapies * Have comorbidities (a) developmental impairment (b) learning disability, (c) personality disorders, and/or (d) any clinically significant medical diseases (by case-file review). * Have organic psychosis or a primary drug or alcohol addiction

Design outcomes

Primary

MeasureTime frameDescription
The Depression Anxiety Stress Scale - short form (DASS-21)Changes will be assessed pre-study; at one week, 3-month and 6-month post-intervention). It is chosen as the primary outcome measurement because scales of anxiety and depression possess the capacity to differentiate from the related state of tension and stress linking with environmental demands and emotional and physical disturbance. It is a 21-item instrument that measures over the past week symptoms of depression, anxiety and stress rated by 4-point severity or frequency scale. The scale is from 0 (did not apply to me at all) to 3 (applied to me very much or most of the time).

Secondary

MeasureTime frameDescription
The WHOQOL-100Changes will be assessed pre-study; at one week, 3-month and 6-month post-interventionIt is a self-administered questionnaire consisting of 100 items and among them, there are six domains: physical, psychological, level of independence, social relationship and environmental and spirituality.
Positive and Negative Syndrome Scale (PANSS)Changes will be assessed pre-study; at one week, 3-month and 6-month post-interventionIt is a 30-item, 7-point scale measuring positive and negative syndrome, differentiation of clinical symptoms and severity of illness. The seven rating points represent increasing levels of psychopathology from 1 (absent) to 7 (extreme).
Acceptance and Action Scale (AAQII)Changes will be assessed pre-study; at one week, 3-month and 6-month post-interventionA seven-item questionnaire that is a commonly used self-report measure of experiential avoidance which also measures psychological inflexibility. The items are rated on a 7-point Likert scale from 1 (never true) to 7 (always true).
The Emotion Regulation Questionnaire (ERQ)Changes will be assessed pre-study; at one week, 3-month and 6-month post-interventionIt is a 10-item scale that was developed to measure participants' tendency to regulate their emotions in cognitive reappraisal and expressive suppression. Items are scored on a 7- point Likert scale ranging from 1 (strongly disagree) to 7 (strongly agree).
The number of re-hospitalizationIt will be measured 6-month post-interventionTo collect information from both the case files and self-reporting
The length of re-hospitalizationIt will be measured 6-month post-interventionTo collect information from both the case files and self-reporting
Five Facet Mindfulness Questionnaire (FFMQ)Changes will be assessed pre-study; at one week, 3-month and 6-month post-interventionIt is a 39-item self-report questionnaire that measures five facets of mindfulness: observing; describing; acting with awareness; non-judging and non-reacting. Items are scored on a 5-point Likert scale ranging from 1 (never or very rarely true) to 5 (very often or always true).

Countries

China, Hong Kong

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026